Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT

Patrick J. Heron reported a 7.50% stake in Arcutis Biotherapeutics, Inc. (Schedule 13D/A)

Event Aug 18, 2025 · Filed Aug 20, 2025

Patrick J. Heron reported a 7.50% stake in Arcutis Biotherapeutics, Inc., 8,943,712 shares, with active intent on Aug 18, 2025. Filed Aug 20, 2025 (Schedule 13D/A).

Stake
7.50%
Shares
8,943,712
Intent
Active
What changed
Stake changed
Filed together
20 holders

The filing in full

HolderStakeShares
Frazier Life Sciences VIII, L.P.7.30%8,785,284
FHM LIFE SCIENCES VIII, L.P.7.40%8,785,284
FHM LIFE SCIENCES VIII, L.L.C.7.40%8,785,291
Frazier Life Sciences X, L.P.0%27,448
FHMLS X, L.P.0%27,448
FHMLS X, L.L.C.0%27,448
Frazier Life Sciences Public Fund, L.P.0.60%664,973
FHMLSP, L.P.0.60%664,973
FHMLSP, L.L.C.0.60%664,973
Frazier Life Sciences Public Overage Fund, L.P.0.20%196,170
FHMLSP Overage, L.P.0.20%196,170
FHMLSP Overage, L.L.C.0.20%196,170
Frazier Life Sciences XI, L.P.0.10%73,087
FHMLS XI, L.P.0.10%73,087
FHMLS XI, L.L.C.0.10%73,087
Frazier Life Sciences XII, L.P.0.10%127,549
FHMLS XII, L.P.0.10%127,549
FHMLS XII, L.L.C.0.10%127,549
James N. Topper7.40%8,843,386
Patrick J. Heron7.50%8,943,712

Source

View original at SEC

Related